These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1176 related items for PubMed ID: 9822169

  • 1. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS, McCarley DL, Zlotecki RA.
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [Abstract] [Full Text] [Related]

  • 2. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 4. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
    Hallqvist A, Rylander H, Björk-Eriksson T, Nyman J.
    Acta Oncol; 2007 Jan 01; 46(7):969-74. PubMed ID: 17851846
    [Abstract] [Full Text] [Related]

  • 5. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct 01; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Oct 01; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 8. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG, Murray N, Warde P.
    Bull Cancer; 1994 Feb 01; 81(2):119-28. PubMed ID: 7894117
    [Abstract] [Full Text] [Related]

  • 9. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
    Bischof M, Debus J, Herfarth K, Muley T, Kappes J, Storz K, Hoffmann H.
    Strahlenther Onkol; 2007 Dec 01; 183(12):679-84. PubMed ID: 18040612
    [Abstract] [Full Text] [Related]

  • 10. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    Schild SE, Bonner JA, Hillman S, Kozelsky TF, Vigliotti AP, Marks RS, Graham DL, Soori GS, Kugler JW, Tenglin RC, Wender DB, Adjei A.
    J Clin Oncol; 2007 Jul 20; 25(21):3124-9. PubMed ID: 17634491
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 12. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):807-11. PubMed ID: 7860392
    [Abstract] [Full Text] [Related]

  • 13. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M.
    Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 03; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

  • 15. [Patterns of relapse in patients with small cell lung cancer--the effect of chest irradiation and prophylactic cranial irradiation combined with intensive chemotherapy on long-term survival].
    Ueoka H, Ohnoshi T, Numata T, Kawahara S, Nishii K, Yonei T, Yamashita H, Moritaka T, Kiura K, Uji H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec 03; 28(12):1581-7. PubMed ID: 1963910
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
    Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):943-51. PubMed ID: 15234027
    [Abstract] [Full Text] [Related]

  • 17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 15; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 18. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
    El Sharouni SY, Kal HB, Barten-Van Rijbroek A, Struikmans H, Battermann JJ, Schramel FM.
    Anticancer Res; 2009 Dec 15; 29(12):5219-24. PubMed ID: 20044639
    [Abstract] [Full Text] [Related]

  • 19. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T, Fukuoka M, Negoro S, Sugiura T, Kawahara M, Kudoh S, Araki J, Nakagawa K, Yokozaki M, Yamakido M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1091-6. PubMed ID: 10945001
    [Abstract] [Full Text] [Related]

  • 20. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Fetscher S, Hasse J, Frommhold H, Pressler K, Mertelsmann R, Engelhardt R, Kanz L.
    Semin Oncol; 1998 Feb 15; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.